Position in VRTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,980,380
-$368,670 QoQ
Shares Held
6,000
-20.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#578
of 1,726 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAMCO INC /NY/ holds $406,272,438 across 24 Biotechnology names. VRTX ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
1,989,386 | $139,316,701 | |
| 2 | ARGX |
Argenx SE
|
136,654 | $126,783,481 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,253,120 | $32,856,806 | |
| 4 | ZLAB |
Zai Lab Ltd
|
1,623,694 | $30,850,186 | |
| 5 | MANE |
Veradermics, Inc
|
229,581 | $28,224,688 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
520,108 | $24,465,880 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
125,000 | $4,423,750 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
6,000 | $2,980,380 |
All Filings in VRTX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,980,380 | 6,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,349,050 | 7,500 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,357,472 | 5,200 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,036,528 | 5,200 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,006,800 | 9,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,817,840 | 12,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,248,600 | 18,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,696,840 | 23,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $10,780,560 | 23,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $9,614,230 | 23,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $9,358,470 | 23,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $7,998,020 | 23,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $8,093,930 | 23,000 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,246,610 | 23,000 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,641,940 | 23,000 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,806,364 | 16,600 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,677,714 | 16,600 | Shares | Defined | 2022-08-15 | |
| 2021-03-31 | $12,917,682 | 60,113 | Shares | Defined | 2021-05-19 | |
| 2020-12-31 | $32,229,449 | 136,369 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $22,681,474 | 83,351 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $23,201,575 | 79,920 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $18,709,770 | 78,629 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||